Viewing Study NCT00531232

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 10:00 PM
Ignite Modification Date: 2026-02-25 @ 5:52 PM
Study NCT ID: NCT00531232
Status: COMPLETED
Last Update Posted: 2022-03-24
First Post: 2007-09-14
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: A Dose Confirmation Study of Oral Clofarabine for Adult Patients Previously Treated for Myelodysplastic Syndromes (MDS)
Sponsor: Genzyme, a Sanofi Company
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Myelodysplastic Syndromes View
None Secondary Acute Myeloid Leukemia (AML) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Previously treated MDS View
None oral clofarabine View
None Intermediate-1, Intermediate-2 and High Risk MDS View
None secondary AML (with history of MDS) View